These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8440570)

  • 21. [Evidence of hormone replacement therapy for osteoporosis].
    Tarakida A; Higuchi T; Mizunuma H
    Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Osteoporosis treatment: the point of view of the gynecologist].
    Lopes P
    Contracept Fertil Sex; 1998 Jun; 26(6):408-11. PubMed ID: 9691516
    [No Abstract]   [Full Text] [Related]  

  • 23. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Estrogen therapy in women with postmenopausal osteoporosis].
    Zarcone R; Carfora E; Sergio F; Bellini P; Longo M; Tartaglia E; Tomasillo G
    Minerva Ginecol; 1997; 49(7-8):355-9. PubMed ID: 9380298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis?
    Schwartz K; Chang SI
    J Fam Pract; 2001 Dec; 50(12):1024-5. PubMed ID: 11742601
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of postmenopausal osteoporosis.
    Liu AC
    N Engl J Med; 1998 Jul; 339(3):202; author reply 203. PubMed ID: 9669920
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
    Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
    Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective strategies to identify postmenopausal women at risk for osteoporosis.
    Levine JP
    Geriatrics; 2007 Nov; 62(11):22-30. PubMed ID: 17999567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
    Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
    J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of aromatase inhibitors on bone metabolism].
    Folkestad L; Bjerregaard JK; Bjarnason NH; Brixen KT
    Ugeskr Laeger; 2007 May; 169(19):1774-9. PubMed ID: 17537350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
    MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347088
    [No Abstract]   [Full Text] [Related]  

  • 33. Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment?
    Laster AJ; Tanner SB
    Rheum Dis Clin North Am; 2011 Aug; 37(3):323-36, v. PubMed ID: 22023894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of bones].
    Qiu MC; Zhu M
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):723-4. PubMed ID: 15949372
    [No Abstract]   [Full Text] [Related]  

  • 35. Perspectives on osteoporosis.
    Kaltenborn KC
    Clin Obstet Gynecol; 1992 Dec; 35(4):901-12. PubMed ID: 1451373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menopausal hormone replacement therapy and risk of breast cancer. Implications for the treatment of osteoporosis in postmenopausal women.
    Lopes P
    Rev Rhum Engl Ed; 1996 May; 63(5):309-11. PubMed ID: 8789875
    [No Abstract]   [Full Text] [Related]  

  • 37. Alendronate in the treatment of osteoporosis.
    Adami S
    Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
    [No Abstract]   [Full Text] [Related]  

  • 38. [Statins with hormone replacement therapy in postmenopausal women with low bone mineral density].
    Shintani M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():488-91. PubMed ID: 15035177
    [No Abstract]   [Full Text] [Related]  

  • 39. Do not use bisphosphonate therapy indefinitely for fracture prevention.
    Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bone turnover in the pathophysiology of osteoporosis.
    Riis BJ
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():9-14; discussion 14-5. PubMed ID: 8624350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.